TCF7L2 and glioblastoma: Five novel fusion transcripts TMEM91-TAL1, CRTC1-ABHD12, VTI1A-TCF7L2, UBE2L3-VPS39 and RAB7A-FOXP1 were identified in the plasma of GBM patients.